Artesunate–pyronaridine–atovaquone–proguanil and artesunate–fosmidomycin–clindamycin compared with standard artesunate–pyronaridine for the treatment of uncomplicated malaria (MultiMal): a randomised, controlled, clinical, phase 2 trial in Gabon and Ghana

Jean Claude Dejon Agobé, Oumou Maïga-Ascofaré, Ayôla Akim Adegnika, Christoph Pfaffendorf, Joseph Marfo Boaheng, Jean Ronald Edoa, Isaac Darko Agyiri, Romeo Bayode Adegbite, Esi Yacoba Bart-Plange, Ebenezer Ahenkan, Dorothea Ekoka Mbassi, Francisca Naana Sarpong, Esther Placca, Dominic Kwabena Kanin, Portia Bakari, Wibke Loag, Jenny Kettenbeil, Sanjeev Krishna, Bertrand Lell, Selidji Todagbe Agnandji, John Humphrey Amuasi, Rella Zoleko-Manego, Ghyslain Mombo-Ngoma, Peter Gottfried Kremsner, Sebastian G Wicha, Michael Ramharter, Johannes Mischlinger

Open source

DOI: 10.1016/j.lanmic.2025.101245
Published: 2026-03
Container: The Lancet Microbe
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.lanmic.2025.101245,
  title = {Artesunate–pyronaridine–atovaquone–proguanil and artesunate–fosmidomycin–clindamycin compared with standard artesunate–pyronaridine for the treatment of uncomplicated malaria (MultiMal): a randomised, controlled, clinical, phase 2 trial in Gabon and Ghana},
  author = {Jean Claude Dejon Agobé and Oumou Maïga-Ascofaré and Ayôla Akim Adegnika and Christoph Pfaffendorf and Joseph Marfo Boaheng and Jean Ronald Edoa and Isaac Darko Agyiri and Romeo Bayode Adegbite and Esi Yacoba Bart-Plange and Ebenezer Ahenkan and Dorothea Ekoka Mbassi and Francisca Naana Sarpong and Esther Placca and Dominic Kwabena Kanin and Portia Bakari and Wibke Loag and Jenny Kettenbeil and Sanjeev Krishna and Bertrand Lell and Selidji Todagbe Agnandji and John Humphrey Amuasi and Rella Zoleko-Manego and Ghyslain Mombo-Ngoma and Peter Gottfried Kremsner and Sebastian G Wicha and Michael Ramharter and Johannes Mischlinger},
  year = {2026},
  journal = {The Lancet Microbe},
  doi = {10.1016/j.lanmic.2025.101245},
  url = {https://doi.org/10.1016/j.lanmic.2025.101245}
}

RIS

TY  - JOUR
TI  - Artesunate–pyronaridine–atovaquone–proguanil and artesunate–fosmidomycin–clindamycin compared with standard artesunate–pyronaridine for the treatment of uncomplicated malaria (MultiMal): a randomised, controlled, clinical, phase 2 trial in Gabon and Ghana
AU  - Jean Claude Dejon Agobé
AU  - Oumou Maïga-Ascofaré
AU  - Ayôla Akim Adegnika
AU  - Christoph Pfaffendorf
AU  - Joseph Marfo Boaheng
AU  - Jean Ronald Edoa
AU  - Isaac Darko Agyiri
AU  - Romeo Bayode Adegbite
AU  - Esi Yacoba Bart-Plange
AU  - Ebenezer Ahenkan
AU  - Dorothea Ekoka Mbassi
AU  - Francisca Naana Sarpong
AU  - Esther Placca
AU  - Dominic Kwabena Kanin
AU  - Portia Bakari
AU  - Wibke Loag
AU  - Jenny Kettenbeil
AU  - Sanjeev Krishna
AU  - Bertrand Lell
AU  - Selidji Todagbe Agnandji
AU  - John Humphrey Amuasi
AU  - Rella Zoleko-Manego
AU  - Ghyslain Mombo-Ngoma
AU  - Peter Gottfried Kremsner
AU  - Sebastian G Wicha
AU  - Michael Ramharter
AU  - Johannes Mischlinger
PY  - 2026
JO  - The Lancet Microbe
DO  - 10.1016/j.lanmic.2025.101245
UR  - https://doi.org/10.1016/j.lanmic.2025.101245
ER  -

APA

Agobé, J. C. D., Maïga-Ascofaré, O., Adegnika, A. A., Pfaffendorf, C., Boaheng, J. M., Edoa, J. R., Agyiri, I. D., Adegbite, R. B., Bart-Plange, E. Y., Ahenkan, E., Mbassi, D. E., Sarpong, F. N., Placca, E., Kanin, D. K., Bakari, P., Loag, W., Kettenbeil, J., Krishna, S., Lell, B., Agnandji, S. T., Amuasi, J. H., Zoleko-Manego, R., Mombo-Ngoma, G., Kremsner, P. G., Wicha, S. G., Ramharter, M., & Mischlinger, J. (2026). Artesunate–pyronaridine–atovaquone–proguanil and artesunate–fosmidomycin–clindamycin compared with standard artesunate–pyronaridine for the treatment of uncomplicated malaria (MultiMal): a randomised, controlled, clinical, phase 2 trial in Gabon and Ghana. The Lancet Microbe. https://doi.org/10.1016/j.lanmic.2025.101245

Source records

crossref · retrieved 2026-09-27T23:05:54.393Z